Synageva BioPharma Corp. (NASDAQ: GEVA)

 
SEC Filings
Date Filed Filing Description View
May 22, 2015 SC 14D9 initial solicitation statement HTML PDF XLS
 
May 22, 2015 SC TO-T other HTML PDF XLS
 
May 11, 2015 425 other HTML PDF
 
 
May 11, 2015 SC14D9C other HTML PDF
 
 
May 11, 2015 425 other HTML PDF
 
 
May 11, 2015 425 other HTML PDF
 
 
May 8, 2015 4 williams, glen HTML PDF XLS
 
May 7, 2015 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS
 
May 6, 2015 8-K current report HTML PDF XLS
 
May 6, 2015 425 other HTML PDF
 
 
1
...
NextLast